{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:22:21Z","timestamp":1776482541386,"version":"3.51.2"},"reference-count":71,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007234","name":"University of Chicago","doi-asserted-by":"publisher","award":["P30CA014599"],"award-info":[{"award-number":["P30CA014599"]}],"id":[{"id":"10.13039\/100007234","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.xcrm.2025.102231","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T10:34:58Z","timestamp":1751884498000},"page":"102231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Activity-attenuated serum albumin-fused interleukin-33 suppresses experimental autoimmune encephalomyelitis"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8510-0497","authenticated-orcid":false,"given":"Erica","family":"Budina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W.","family":"Reda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyse A.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ani","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip S.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Emiliano","family":"G\u00f3mez Medell\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Rin","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen R.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan T.K.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha-Na","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Hultgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Tremain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ako","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0276-5456","authenticated-orcid":false,"given":"Jeffrey A.","family":"Hubbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102231_bib1","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple Sclerosis: Mechanisms and Immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.xcrm.2025.102231_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib3","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of Multiple Sclerosis: A Review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.xcrm.2025.102231_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102231_bib5","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.4049\/jimmunol.180.4.2443","article-title":"IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes","volume":"180","author":"Humphreys","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fimmu.2019.00364","article-title":"IL33: Roles in Allergic Inflammation and Therapeutic Perspectives","volume":"10","author":"Chan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib7","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cell.2015.08.021","article-title":"A Distinct Function of Regulatory T Cells in Tissue Protection","volume":"162","author":"Arpaia","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102231_bib8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102231_bib9","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201234","article-title":"T reg cell\u2013intrinsic requirements for ST2 signaling in health and neuroinflammation","volume":"218","author":"Hemmers","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102231_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161507","article-title":"IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGF\u03b2 Release","volume":"11","author":"Siede","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102231_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/blood-2015-12-684142","article-title":"Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD","volume":"128","author":"Matta","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102231_bib12","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1073\/pnas.95.12.6930","article-title":"T1\/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function","volume":"95","author":"L\u00f6hning","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.xcrm.2025.102231_bib13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"Neill","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102231_bib14","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.4049\/jimmunol.0901575","article-title":"IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation","volume":"183","author":"Kurowska-Stolarska","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib15","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.1400481","article-title":"IL-33 Is an Unconventional Alarmin That Stimulates IL-2 Secretion by Dendritic Cells To Selectively Expand IL-33R\/ST2+ Regulatory T Cells","volume":"193","author":"Matta","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib17","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/mi.2017.5","article-title":"TH17 cells express ST2 and are controlled by the alarmin IL-33 in the small intestine","volume":"10","author":"Pascual-Reguant","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/imm.13203","article-title":"Interleukin-33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response","volume":"160","author":"Chen","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.xcrm.2025.102231_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3390\/antib2030426","article-title":"Molecular Engineering of Therapeutic Cytokines","volume":"2","author":"Vazquez-Lombardi","year":"2013","journal-title":"Antibodies"},{"key":"10.1016\/j.xcrm.2025.102231_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/path.2476","article-title":"Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis","volume":"217","author":"Van Zwam","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.xcrm.2025.102231_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00063030-200822010-00002","article-title":"Fc-Based Cytokines: Prospects for Engineering Superior Therapeutics","volume":"22","author":"Jazayeri","year":"2008","journal-title":"BioDrugs"},{"key":"10.1016\/j.xcrm.2025.102231_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib23","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/eji.201141947","article-title":"IL-33 attenuates EAE by suppressing IL-17 and IFN-\u03b3 production and inducing alternatively activated macrophages: Immunomodulation","volume":"42","author":"Jiang","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40591-016-0048-8","article-title":"Albumin-based drug delivery: harnessing nature to cure disease","volume":"4","author":"Larsen","year":"2016","journal-title":"Mol. Cell. Ther."},{"key":"10.1016\/j.xcrm.2025.102231_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41551-020-00627-3","article-title":"Prolonged residence of an albumin\u2013IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis","volume":"5","author":"Ishihara","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2025.102231_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.smim.2013.10.006","article-title":"Special aspects of interleukin-33 and the IL-33 receptor complex","volume":"25","author":"Martin","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.immuni.2012.06.020","article-title":"The Transcription Factor GATA-3 Controls Cell Fate and Maintenance of Type 2 Innate Lymphoid Cells","volume":"37","author":"Hoyler","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102231_bib28","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1073\/pnas.1003988107","article-title":"Systemically dispersed innate IL-13\u2013expressing cells in type 2 immunity","volume":"107","author":"Price","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.xcrm.2025.102231_bib29","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1410700111","article-title":"Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells","volume":"111","author":"Lefran\u00e7ais","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.xcrm.2025.102231_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/cells11010107","article-title":"IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity","volume":"11","author":"Cayrol","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2025.102231_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99208","article-title":"From proteomics to discovery of first-in-class ST2 inhibitors active in vivo","volume":"3","author":"Ramadan","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2025.102231_bib32","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102231_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/NAN.0b013e31824d2271","article-title":"Subcutaneous Drug Delivery: A Route to Increased Safety, Patient Satisfaction, and Reduced Costs","volume":"35","author":"Dychter","year":"2012","journal-title":"J. Infus. Nurs."},{"key":"10.1016\/j.xcrm.2025.102231_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102231_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGF\u03b2 in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102231_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41423-019-0210-8","article-title":"Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses","volume":"16","author":"Gurram","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib37","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/eji.200737547","article-title":"IL-33 is a chemoattractant for human Th2 cells","volume":"37","author":"Komai-Koma","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib38","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1073\/pnas.0906988106","article-title":"IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells","volume":"106","author":"Guo","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.xcrm.2025.102231_bib39","doi-asserted-by":"crossref","first-page":"1827901","DOI":"10.1155\/2018\/1827901","article-title":"IL-33 Protects Mice against DSS-Induced Chronic Colitis by Increasing Both Regulatory B Cell and Regulatory T Cell Responses as Well as Decreasing Th17 Cell Response","volume":"2018","author":"Zhu","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.xcrm.2025.102231_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580304","article-title":"The Role of Gamma-Delta T Cells in Diseases of the Central Nervous System","volume":"11","author":"Wo","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib41","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4060::AID-IMMU4060>3.0.CO;2-S","article-title":"Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 \u2013 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR \u03b4 chain gene","volume":"29","author":"Spahn","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-5728(92)90016-E","article-title":"Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein","volume":"38","author":"McRae","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib43","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s44222-023-00030-y","article-title":"Engineering cytokine therapeutics","volume":"1","author":"Deckers","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.xcrm.2025.102231_bib44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00262-004-0624-7","article-title":"Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice","volume":"54","author":"Melder","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.xcrm.2025.102231_bib45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.41585","article-title":"Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin-10 in Murine Models","volume":"73","author":"Yuba","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.xcrm.2025.102231_bib46","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1185\/03007990902779186","article-title":"Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C","volume":"25","author":"Rustgi","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.xcrm.2025.102231_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/10799900360520423","article-title":"An IFN- \u03b2 -Albumin Fusion Protein That Displays Improved Pharmacokinetic and Pharmacodynamic Properties in Nonhuman Primates","volume":"23","author":"Sung","year":"2003","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.xcrm.2025.102231_bib48","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1023\/A:1020917732218","article-title":"Albugranin, a Recombinant Human Granulocyte Colony Stimulating Factor (G-CSF) Genetically Fused to Recombinant Human Albumin Induces Prolonged Myelopoietic Effects in Mice and Monkeys","volume":"19","author":"Halpern","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.xcrm.2025.102231_bib49","doi-asserted-by":"crossref","first-page":"E1520","DOI":"10.1073\/pnas.1710401115","article-title":"Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility","volume":"115","author":"Russi","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.xcrm.2025.102231_bib50","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.4049\/jimmunol.1500068","article-title":"Cutting Edge: c-Kit Signaling Differentially Regulates Type 2 Innate Lymphoid Cell Accumulation and Susceptibility to Central Nervous System Demyelination in Male and Female SJL Mice","volume":"194","author":"Russi","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib51","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.4049\/jimmunol.155.8.4052","article-title":"Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease","volume":"155","author":"Cua","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib52","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.2147\/OTT.S221340","article-title":"The Role Of PD-1\/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy","volume":"12","author":"Cai","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.xcrm.2025.102231_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2013.06.006","article-title":"Treg and CTLA-4: Two intertwining pathways to immune tolerance","volume":"45","author":"Walker","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.xcrm.2025.102231_bib54","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ni.3799","article-title":"Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues","volume":"18","author":"Delacher","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib55","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.immuni.2011.08.012","article-title":"An Essential Role of the Transcription Factor GATA-3 for the Function of Regulatory T Cells","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102231_bib56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.it.2016.03.007","article-title":"IL-33 in T Cell Differentiation, Function, and Immune Homeostasis","volume":"37","author":"Peine","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib57","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.4049\/jimmunol.1100519","article-title":"IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival","volume":"187","author":"Turnquist","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib58","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/ajt.16266","article-title":"IL-33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation","volume":"21","author":"Kawai","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2025.102231_bib59","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2119\/molmed.2011.00428","article-title":"Interleukin-33 Ameliorates Experimental Colitis through Promoting Th2\/Foxp3+ Regulatory T-Cell Responses in Mice","volume":"18","author":"Duan","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.xcrm.2025.102231_bib60","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102231_bib61","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1189\/jlb.1207830","article-title":"Induction of IL-33 expression and activity in central nervous system glia","volume":"84","author":"Hudson","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2025.102231_bib62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2011.02.045","article-title":"Production and functions of IL-33 in the central nervous system","volume":"1385","author":"Yasuoka","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.xcrm.2025.102231_bib63","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2015.01.013","article-title":"The Glia-Derived Alarmin IL-33 Orchestrates the Immune Response and Promotes Recovery following CNS Injury","volume":"85","author":"Gadani","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.xcrm.2025.102231_bib64","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2025.102231_bib65","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ana.21744","article-title":"Pathogenic CD8(+) T cells in multiple sclerosis","volume":"66","author":"Friese","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2025.102231_bib66","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2018.03.025","article-title":"T Cell Receptor-Regulated TGF-\u03b2 Type I Receptor Expression Determines T Cell Quiescence and Activation","volume":"48","author":"Tu","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102231_bib67","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymthe.2017.09.001","article-title":"Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple Sclerosis","volume":"26","author":"Keeler","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102231_bib68","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41551-023-01086-2","article-title":"Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses","volume":"7","author":"Tremain","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2025.102231_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau3259","article-title":"Targeted antibody and cytokine cancer immunotherapies through collagen affinity","volume":"11","author":"Ishihara","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102231_bib70","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/978-1-60761-720-4_19","article-title":"Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease","volume":"900","author":"McCarthy","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2025.102231_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125003040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125003040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:43:22Z","timestamp":1762638202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125003040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2666379125003040"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102231","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity-attenuated serum albumin-fused interleukin-33 suppresses experimental autoimmune encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102231"}}